Literature DB >> 3366434

The histopathology and staging of carcinoma of the ampulla of Vater.

I C Talbot1, J P Neoptolemos, D E Shaw, D Carr-Locke.   

Abstract

Review of 26 resected ampullary carcinomas revealed intestinal type adenocarcinoma in all but one and overtly papillary carcinoma in only one case. Co-existing adenoma of the ampulla was present in 11 cases, over half of which were low-grade carcinomas. Flat duct epithelial dysplasia was present in a further eight cases, the adenocarcinoma in only two of these being well differentiated. The estimated 5 year survival rate, overall, was 52% and, with well differentiated adenocarcinoma, 75%. We recommend a new staging system, based on extent of local and lymph node spread: I = invasion confined to wall of common bile duct; II = infiltration of duodenal or retroperitoneal tissues, excluding pancreas; III = infiltration of pancreas; IV = metastasis to nearby lymph nodes. Long-term survival correlates inversely with stage, both by univariate analysis and independently of grade, so that a simple scoring system, based on a combination of both grade and stage, is an excellent predictor of the long-term outcome, defining two groups, with 5 year survival rates of 79% and 0% (P less than 0.001).

Entities:  

Mesh:

Year:  1988        PMID: 3366434     DOI: 10.1111/j.1365-2559.1988.tb01926.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  10 in total

1.  Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases.

Authors:  A Dorandeu; J L Raoul; F Siriser; N Leclercq-Rioux; M Gosselin; E D Martin; M P Ramée; B Launois
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Histological evaluation of preoperative biopsies from ampulla vateri.

Authors:  Gábor Elek; Sándor Gyôri; Bernadett Tóth; Akos Pap
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

3.  Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients.

Authors:  P Domizio; I C Talbot; A D Spigelman; C B Williams; R K Phillips
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

4.  Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee).

Authors:  A D Spigelman; I C Talbot; C Penna; K P Nugent; R K Phillips; C Costello; J J DeCosse
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

5.  Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations.

Authors:  A Scarpa; P Capelli; G Zamboni; T Oda; K Mukai; F Bonetti; G Martignoni; C Iacono; G Serio; S Hirohashi
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

6.  Adenoma of the ampulla of Vater: putative precancerous lesion.

Authors:  K Yamaguchi; M Enjoji
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

7.  Review of standards for reporting results of treatment of exocrine pancreatic cancer.

Authors:  A Andrén-Sandberg; C Cedercrantz
Journal:  Int J Pancreatol       Date:  1993-12

8.  Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.

Authors:  Luciana Bertocco de Paiva Haddad; Rosely Antunes Patzina; Sônia Penteado; André Luiz Montagnini; José Eduardo Monteiro da Cunha; Marcel Cerqueira César Machado; José Jukemura
Journal:  J Gastrointest Surg       Date:  2010-01-27       Impact factor: 3.452

9.  Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.

Authors:  Calogero Iacono; Giuseppe Verlato; Giuseppe Zamboni; Aldo Scarpa; Ettore Montresor; Paola Capelli; Luca Bortolasi; Giovanni Serio
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.267

10.  Prognostic factors for long-term survival in patients with ampullary carcinoma: the results of a 15-year observation period after pancreaticoduodenectomy.

Authors:  Fritz Klein; Dietmar Jacob; Marcus Bahra; Uwe Pelzer; Gero Puhl; Alexander Krannich; Andreas Andreou; Safak Gül; Olaf Guckelberger
Journal:  HPB Surg       Date:  2014-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.